Provided by Tiger Trade Technology Pte. Ltd.

ASTRAZENECA PLC ADRhedged

53.28
0.0000
Volume:- -
Turnover:- -
Market Cap:1.60M
PE:- -
High:53.28
Open:53.28
Low:53.28
Close:53.28
52wk High:56.90
52wk Low:44.36
Shares:30.00K
Float Shares:10.00K
Volume Ratio:2.68
T/O Rate:- -
Dividend:0.58
Dividend Rate:1.08%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Top Midday Stories: Amazon Market Cap Hits $3 Trillion; AstraZeneca, Bristol Myers Squibb Reportedly Discuss $400 Billion Combination

MT Newswires Live
·
Aug 03

AstraZeneca PLC Stock (AZN) Moved Down by 8.54% on Aug 3: Key Drivers Unveiled

TradingKey
·
Aug 03

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Aug 03

Bristol Myers Squibb Stock Falls on Report of $400 Billion Merger Talks with Big Rival

Dow Jones
·
Aug 03

AstraZeneca Down Nearly 8%, on Pace for Largest Percent Decrease Since April 2025

Dow Jones
·
Aug 03

Potential merger between AstraZeneca and Bristol-Myers Squibb would create a cancer drug powerhouse, but analysts call it a 'strange' deal

Deep News
·
Aug 03

Sector Update: Healthcare

MT Newswires Live
·
Aug 03

Pre-Market: Nasdaq Futures Gain 0.32% as US and Japan Jointly Intervene in Currency Markets

Deep News
·
Aug 03

U.S. Stocks on the MOVE-Atkore, Integer, Airlines

Reuters
·
Aug 03

US Stocks-Wall St Futures Gain on Mideast Deal Hopes; Healthcare in Focus

Reuters
·
Aug 03

Citi views report of AstraZeneca, Bristol Myers talks as surprising

TIPRANKS
·
Aug 03

AstraZeneca Investors Might Question Pipeline After Reports of Merger Talks

Dow Jones
·
Aug 03

Stocks to Watch: Bristol Myers Squibb, Alibaba, Palantir

Dow Jones
·
Aug 03

AstraZeneca Could Want to Move Closer to U.S. Market

Dow Jones
·
Aug 03

AstraZeneca Can Hit Revenue Target on Its Own

Dow Jones
·
Aug 03

AstraZeneca in discussions to combine with Bristol Myers for $400B, FT says

TIPRANKS
·
Aug 03

AstraZeneca Explores Blockbuster Bristol-Myers Squibb Deal Reshaping Global Pharma Landscape

Stock News
·
Aug 03

Astrazeneca, Daiichi Sankyo's Breast Cancer Therapy Receives EU approval

MT Newswires Live
·
Jul 31

Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanks

Benzinga Earnings
·
Jul 31

Xencor Shares Rise After Settlement Deal With Alexion

MT Newswires Live
·
Jul 31